Avdoralimab
Showing 1 - 4 of 4
Bullous Pemphigoid Trial in Nice, Marseille, Montpellier (Avdoralimab (IPH5401), Control)
Recruiting
- Bullous Pemphigoid
- Avdoralimab (IPH5401)
- Control
-
Nice, Alpes-Maritimes, France
- +3 more
Feb 18, 2022
SARS-CoV-2 (COVID-19) Infection, Advanced or Metastatic Hematological or Solid Tumor Trial in France (Autophagy inhibitor
Completed
- SARS-CoV-2 (COVID-19) Infection
- Advanced or Metastatic Hematological or Solid Tumor
- Autophagy inhibitor (GNS651)
- +3 more
-
Lyon, Rhône, France
- +11 more
Sep 29, 2022
COVID Trial in Marseille (avdoralimab, Placebo)
Completed
- COVID
- avdoralimab
- Placebo
-
Marseille, FranceAssistance Publique Hôpitaux de Marseille
May 26, 2021
Advanced Solid Tumors Trial in France, United States (IPH5401 and Durvalumab)
Terminated
- Advanced Solid Tumors
- IPH5401 and Durvalumab
-
Louisville, Kentucky
- +11 more
Jan 12, 2022